Thursday, October 29, 2020

Anticholinergic Drugs Increase Risk of Cognitive Decline

A new study finds that anticholinergic drugs, like antidepressants and antipsychotics, are associated with mild cognitive decline.

Researchers: It’s Time to Stop Recommending Antidepressants for Depression

Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.
antipsychotic drugs

Antipsychotic Augmentation Increases Risk of Death

A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.

Greater Exposure to Antipsychotics Associated with Worse Long-Term Outcomes

A new study finds adverse long-term consequences associated with the increased use of antipsychotics in first-episode psychosis.

Psychiatry’s Top Experts Acknowledge Lasting Harms of Antidepressant Withdrawal

Royal College of Psychiatrists’ former president demands support for patients coming off antidepressants.

Further Results Confirm Antidepressants Increase Risk of Violent Crime By 26%

Taking an SSRI antidepressant was associated with a 26% increased risk of violent crime conviction.

Unblinding in Antidepressant Trials Biases Results

Studies that compare the effectiveness of different antidepressant drugs are unreliable, according to new research in BMC Psychiatry.

“I Found My Lion’s Roar”: Ro Speight on Combining Peer Support and Open Dialogue

MIA's Ana Florence interviews recovery advocate Ro Speight about her journey from receiving Peer Support to working as a facilitator in Peer Partnered Open Dialogue.

Tapering Strips Help People Stop Using Antidepressants, Study Finds

A new study by Peter Groot and Jim van Os investigated whether tapering strips can help people stop using antidepressants.

Very Slow Taper Best for Antipsychotic Discontinuation

An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.

Antipsychotics Associated with Severe COVID-19 and Fatal Outcomes

A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.

Strategies for Tapering and Discontinuing Antidepressants

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

Service-User Knowledge Helps Researchers Develop Psychiatric Drug Tapering Approaches

New strategies for tapering psychiatric drugs achieved by acknowledging withdrawal symptoms and valuing service-users’ first-hand knowledge.

Mental Health and Emotion in the Digital Age: An Interview with Ian Tucker

MIA's Tim Beck interviews psychologist Ian Tucker about the relationships between digital technologies, emotion, and mental health.

For People “At Risk for Psychosis,” Antipsychotics Associated with Worse Outcomes

Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.

Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

Youth Antidepressant Use Associated With Increased Suicide and Self-Harm

National data on rates of youth antidepressant prescription, suicide, and self-harm in Australia sparks public health debate about drug safety.

Study Finds SSRIs Associated with Increased Risk for Violent Crime

Study finds an apparent connection between SSRIs, the most commonly prescribed type of antidepressant, and increased risk of violent crime.

JAMA Psychiatry Retracts Antidepressant Study

Once an appropriate statistical method was used, the study findings were “no longer valid,” according to the editors of JAMA and JAMA Psychiatry.

Review Documents Severe Withdrawal Effects of Psychiatric Drugs

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.

New Analysis: Antidepressants Still Linked to Suicide

“This is remarkable for drugs that are used to treat depressive symptoms,” write the researchers.

When Psychology Speaks for You, Without You: Sunil Bhatia on Decolonizing Psychology

MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.

Neuropsychological Tests Reveal Consequences of Polypharmacy

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

Antipsychotic Trials Show Increasing Placebo Response and Declining Drug Response

A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.

Antidepressant Use Continues to Climb Among Youth on Medicaid

New study finds that Medicaid enrolled youth were 14 times more likely to be on an antidepressant in 2014 than in 1987.

Follow Us

19,639FansLike
11,994FollowersFollow
4,730SubscribersSubscribe